Filippo Ansaldi

7.3k citations

167 papers · 4.7k indexed · h-index 39

Impact in

Hepatology top 1%
- Hepatitis C virus research
Epidemiology top 0.5%
- Influenza Virus Research Studies
- Respiratory viral infections research
- Pneumonia and Respiratory Infections
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment

Papers in ⓘ

Epidemiology 121
- Influenza Virus Research Studies 56
- Respiratory viral infections research 51
- Pneumonia and Respiratory Infections 33
- Hepatitis B Virus Studies 15
- Virology and Viral Diseases 12
Infectious Diseases 27

Co-authors: Giancarlo Icardi (87 shared papers)Paolo Durando (57 shared papers)Andrea Orsi (38 shared papers)Roberto Gasparini (27 shared papers)Cecilia Trucchi (28 shared papers)Laura Sticchi (30 shared papers)Matteo Bassetti (16 shared papers)Daniela de Florentiis (21 shared papers)
Journals: Human Vaccines & Immunotherapeutics (14 papers)Journal of Medical Virology (12 papers)Vaccine (11 papers)Vaccines (8 papers)Journal of Clinical Microbiology (4 papers)
Partner nations: Italy United States United Kingdom

In The Last Decade

Filippo Ansaldi

160 papers receiving 4.6k citations

Peers

Countries citing papers authored by Filippo Ansaldi

Since Specialization

Citations

This map shows the geographic impact of Filippo Ansaldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Filippo Ansaldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Filippo Ansaldi more than expected).

Fields of papers citing papers by Filippo Ansaldi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Filippo Ansaldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Filippo Ansaldi. The network helps show where Filippo Ansaldi may publish in the future.

Co-authors

The 25 scholars most cited alongside Filippo Ansaldi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Filippo Ansaldi Line = papers co-authored together Filippo Ansaldi links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 167 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality Intensive Care Medicine ·Matteo Bassetti, Elda Righi, Filippo Ansaldi, Maria Merelli, Cecilia Trucchi, Gennaro De Pascale, Ana Díaz‐Martín, Roberto Luzzati, Chiara Rosin, Leonel Lagunes, Enrico Maria Trecarichi, Maurizio Sanguinetti, Brunella Posteraro, José Garnacho‐Montero, Assunta Sartor, Jordi Rello, Giorgio Della Rocca, Massimo Antonelli, Mario Tumbarello	2014	197
2	Case definitions for human poisonings postulated to palytoxins exposure Toxicon ·Aurelia Tubaro, Paolo Durando, Giorgia Del Favero, Filippo Ansaldi, Giancarlo Icardi, Jonathan R. Deeds, Silvio Sosa	2011	155
3	Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy Journal of Medical Virology ·Filippo Ansaldi, Bianca Bruzzone, Stefania Salmaso, Maria Cristina Rota, Paolo Durando, Roberto Gasparini, Giancarlo Icardi	2005	142
4	Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections Journal of Antimicrobial Chemotherapy ·Matteo Bassetti, Ernestina Repetto, Elda Righi, Silvia Boni, M. Diverio, M.P. Molinari, Michele Mussap, Stefania Artioli, Filippo Ansaldi, Paolo Durando, Giovanni Orengo, F. Bobbio Pallavicini, Claudio Viscoli	2007	135
5	Surgical Prevention of Arm Lymphedema After Breast Cancer Treatment Annals of Surgical Oncology ·Francesco Boccardo, Federico Casabona, Daniele Friedman, Maria Ausiliatrice Puglisi, Franco De Cian, Filippo Ansaldi, Corradino Campisi	2011	123
6	Hepatitis C virus in the new era: Perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy World Journal of Gastroenterology ·Filippo Ansaldi	2014	115
7	Cross-protection by MF59™-adjuvanted influenza vaccine: Neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza viruses Vaccine ·Filippo Ansaldi, Sabrina Bacilieri, Paolo Durando, Laura Sticchi, Laura Valle, Emanuele Montomoli, Giancarlo Icardi, Roberto Gasparini, Pietro Crovari	2008	108
8	Influenza control in the 21st century: Optimizing protection of older adults Vaccine ·Arnold S. Monto, Filippo Ansaldi, Richard Aspinall, Janet E. McElhaney, Luis F. Montaño, Kristin L. Nichol, Joan Puig‐Barberà, Joe Schmitt, Iain Stephenson	2009	108
9	Attitudes and Beliefs on Influenza Vaccination during the COVID-19 Pandemic: Results from a Representative Italian Survey Vaccines ·Alexander Domnich, Maura Cambiaggi, Alessandro Vasco, Luca Maraniello, Filippo Ansaldi, Vincenzo Baldo, Paolo Bonanni, Giovanna Elisa Calabrò, Claudio Costantino, Chiara de Waure, Giovanni Gabutti, Vincenzo Restivo, Caterina Rizzo, Francesco Vitale, Riccardo Grassi	2020	97
10	Ostreopsis ovata and human health: epidemiological and clinical features of respiratory syndrome outbreaks from a two-year syndromic surveillance, 2005-06, in north-west Italy Weekly releases (1997–2007) ·Paolo Durando, Filippo Ansaldi, P Oreste, P Moscatelli, Lorenzo Marensi, Claudio Grillo, Roberto Gasparini, Giancarlo Icardi, (unknown)	2007	95
11	Clinical and Therapeutic Aspects of Candidemia: A Five Year Single Centre Study PLoS ONE ·Matteo Bassetti, Maria Merelli, Filippo Ansaldi, Daniela de Florentiis, Assunta Sartor, Claudio Scarparo, Astrid Callegari, Elda Righi	2015	85
12	Antibody response against heterogeneous circulating influenza virus strains elicited by MF59- and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolates Vaccine ·Filippo Ansaldi, Marta Zancolli, Paolo Durando, Emanuele Montomoli, Laura Sticchi, Giuseppe Del Giudice, Giancarlo Icardi	2010	82
13	Impaired Response to Influenza Vaccine Associated with Persistent Memory B Cell Depletion in Non-Hodgkin’s Lymphoma Patients Treated with Rituximab-Containing Regimens The Journal of Immunology ·Davide Bedognetti, Gabriele Zoppoli, Carlotta Massucco, Elisa Zanardi, Simona Zupo, Andrea Bruzzone, Mario Roberto Sertoli, Enrico Balleari, Omar Racchi, Marco Messina, Graziano Caltabiano, Giancarlo Icardi, Paolo Durando, Francesco M. Marincola, Francesco Boccardo, Manlio Ferrarini, Filippo Ansaldi, Andrea De Maria	2011	78
14	Mother‐to‐infant transmission of hepatitis C virus: Rate of infection and assessment of viral load and IgM anti‐HCV as risk factors* Journal of Medical Virology ·G. Dal Molin, Pierlanfranco D’Agaro, Filippo Ansaldi, Giovanni Ciana, C. Fertz, Salvatore Alberico, Cesare Campello	2002	77
15	Incidence of candidaemia and relationship with fluconazole use in an intensive care unit Journal of Antimicrobial Chemotherapy ·Matteo Bassetti, Filippo Ansaldi, Laura Ambra Nicolini, Emanuele Malfatto, M.P. Molinari, Michele Mussap, Barbara Rebesco, F. Bobbio Pallavicini, Giancarlo Icardi, Claudio Viscoli	2009	77
16	Novel Approach To Reduce the Hepatitis C Virus (HCV) Window Period: Clinical Evaluation of a New Enzyme-Linked Immunosorbent Assay for HCV Core Antigen Journal of Clinical Microbiology ·Giancarlo Icardi, Filippo Ansaldi, Bianca Bruzzone, Paolo Durando, Stephen Lee, Carla de Luigi, Pietro Crovari	2001	76
17	Quadrivalent influenza vaccine: a new opportunity to reduce the influenza burden. PubMed ·Valentino Tisa, Ilaria Barberis, Valeria Faccio, Chiara Paganino, Cecilia Trucchi, Mariano Martini, Filippo Ansaldi	2016	67
18	Universal childhood immunisation against Streptococcus pneumoniae: The five-year experience of Liguria Region, Italy Vaccine ·Paolo Durando, Pietro Crovari, Filippo Ansaldi, Laura Sticchi, Camilla Sticchi, Valter Turello, Lorenzo Marensi, R. Giacchino, Anna Timitilli, R Carloni	2009	64
19	Effectiveness of pneumococcal vaccines in preventing pneumonia in adults, a systematic review and meta-analyses of observational studies PLoS ONE ·Myint Tin Tin Htar, Anke L. Stuurman, Germano Ferreira, Cristiano Alicino, Kaatje Bollaerts, Chiara Paganino, Ralf René Reinert, H. J. Schmitt, Cecilia Trucchi, Thomas Vestraeten, Filippo Ansaldi	2017	63
20	Adjuvants and alternative routes of administration towards the development of the ideal influenza vaccine Human Vaccines ·Paolo Durando, Rocco Iudici, Cristiano Alicino, Marisa Alberti, Daniela de Florentis, Filippo Ansaldi, Giancarlo Icardi	2011	61

About Filippo Ansaldi

Filippo Ansaldi is a scholar working on Epidemiology, Infectious Diseases, Hepatology, Immunology and Microbiology, having authored 167 papers that have together received 4.7k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (56 papers), Respiratory viral infections research (51 papers), Pneumonia and Respiratory Infections (33 papers), Hepatitis C virus research (19 papers), Hepatitis B Virus Studies (15 papers), Bacterial Infections and Vaccines (14 papers), Vaccine Coverage and Hesitancy (13 papers) and Virology and Viral Diseases (12 papers). The work is most often cited by research in Hepatology (724 citations), Epidemiology (3.0k citations), Applied Microbiology and Biotechnology (144 citations), Infectious Diseases (1.2k citations) and Health (496 citations). Filippo Ansaldi has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Giancarlo Icardi, Paolo Durando, Andrea Orsi, Roberto Gasparini, Cecilia Trucchi, Laura Sticchi, Matteo Bassetti, Daniela de Florentiis, Chiara Paganino and Pietro Crovari. Their work appears in journals such as Human Vaccines & Immunotherapeutics, Journal of Medical Virology, Vaccine, Vaccines and Journal of Clinical Microbiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact